Therefore, we suggest that AT1R blocker may protect hypertensive COVID-19 patients from heart injury caused by SARS-CoV-2 infection via the ACE2-Ang-(1-7)-Mas-R axis (Scheme 1). This evidence concerns the gene AGTR1 and COVID-19.